These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [The assessment of pathological PSA values by the general practitioner--observation or intervention?]. Braun KP; Brookman-Amissah S; May M; Grassmel Y; Hoschke B; Braun V Aktuelle Urol; 2009 May; 40(3):171-4. PubMed ID: 19479670 [TBL] [Abstract][Full Text] [Related]
4. PSA doubling time as a predictive factor on repeat biopsy for detection of prostate cancer. Shimbo M; Tomioka S; Sasaki M; Shima T; Suzuki N; Murakami S; Nakatsu H; Shimazaki J Jpn J Clin Oncol; 2009 Nov; 39(11):727-31. PubMed ID: 19674994 [TBL] [Abstract][Full Text] [Related]
5. Inverse association between histologic inflammation in needle biopsy specimens and prostate cancer in men with serum PSA of 10-50 ng/mL. Terakawa T; Miyake H; Kanomata N; Kumano M; Takenaka A; Fujisawao M Urology; 2008 Dec; 72(6):1194-7. PubMed ID: 18829081 [TBL] [Abstract][Full Text] [Related]
6. [Differentiation of prostate cancer from benign prostatic disease by total prostate specific antigen dynamic profiles after transrectal prostate biopsy]. Shao Q; Song J; Zhou ZJ; Du LD Zhonghua Nan Ke Xue; 2008 Jul; 14(7):597-601. PubMed ID: 18686378 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of high-grade prostatic intraepithelial neoplasia (HGPIN): risk of prostatic cancer on repeat biopsies. Gallo F; Chiono L; Gastaldi E; Venturino E; Giberti C Urology; 2008 Sep; 72(3):628-32. PubMed ID: 18279918 [TBL] [Abstract][Full Text] [Related]
8. Free PSA/total PSA ratio increases the detection rate of prostate cancer in twelve-core biopsy. Yokomizo Y; Miyoshi Y; Nakaigawa N; Makiyama K; Ogawa T; Yao M; Kubota Y; Uemura H Urol Int; 2009; 82(3):280-5. PubMed ID: 19440014 [TBL] [Abstract][Full Text] [Related]
9. Value of prostate-specific antigen and prostate-specific antigen density in detection of prostate cancer in an Iranian population of men. Ghafoori M; Varedi P; Hosseini SJ; Asgari M; Shakiba M Urol J; 2009; 6(3):182-8. PubMed ID: 19711272 [TBL] [Abstract][Full Text] [Related]
10. Is it necessary to detect all prostate cancers in men with serum PSA levels <3.0 ng/ml? A comparison of biopsy results of PCPT and outcome-related information from ERSPC. Schröder FH; Bangma CH; Roobol MJ Eur Urol; 2008 May; 53(5):901-8. PubMed ID: 18262712 [TBL] [Abstract][Full Text] [Related]
11. Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia. Helfand BT; Anderson CB; Fought A; Kim DY; Vyas A; McVary KT Urology; 2009 Jul; 74(1):177-83. PubMed ID: 19428074 [TBL] [Abstract][Full Text] [Related]
12. Comparison of 6- and 12-core prostate biopsy in Taiwanese men: impact of total prostate-specific antigen, prostate-specific antigen density and prostate volume on prostate cancer detection. Chiang IN; Chang SJ; Pu YS; Huang KH; Yu HJ; Huang CY Urol Int; 2009; 82(3):270-5. PubMed ID: 19440012 [TBL] [Abstract][Full Text] [Related]
13. Prostate cancer screening with prostate-specific antigen in hemodialysis patients. Horinaga M; Kitamura K; Saito S; Ukimura O; Nakanoma T; Okihara K; Kitagawa M; Nakanishi H; Miki T Urol Int; 2007; 78(4):334-7. PubMed ID: 17495492 [TBL] [Abstract][Full Text] [Related]
15. Ten year trend in prostate cancer screening with high prostate-specific antigen exposure rate in Japan. Okihara K; Kitamura K; Okada K; Mikami K; Ukimura O; Miki T Int J Urol; 2008 Feb; 15(2):156-60; discussion 161. PubMed ID: 18269453 [TBL] [Abstract][Full Text] [Related]
16. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer. Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800 [TBL] [Abstract][Full Text] [Related]
17. The impact of reducing the prostate-specific antigen threshold and including isoform reflex tests on the performance characteristics of a prostate-cancer detection programme. Roddam AW; Hamdy FC; Allen NE; Price CP; BJU Int; 2007 Sep; 100(3):514-7. PubMed ID: 17542987 [TBL] [Abstract][Full Text] [Related]
18. [The detection rate of prostate cancer in different prostate-specific antigen (PSA) levels in Chinese men]. Li M; Na YQ Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(1):16-8. PubMed ID: 18346372 [TBL] [Abstract][Full Text] [Related]
19. Population-based screening for prostate cancer by measuring total serum prostate-specific antigen in Iran. Hosseini SY; Moharramzadeh M; Ghadian AR; Hooshyar H; Lashay AR; Safarinejad MR Int J Urol; 2007 May; 14(5):406-11. PubMed ID: 17511722 [TBL] [Abstract][Full Text] [Related]
20. An elevated PSA, which normalizes, does not exclude the presence of prostate cancer. Boddy JL; Pike DJ; Al-Hayek S; Shaida N; Malone PR Prostate Cancer Prostatic Dis; 2005; 8(4):349-52. PubMed ID: 16010283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]